Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as ...

Today, the American Kidney Fund (AKF) is convening its seventh annual national summit on Unknown Causes of Kidney Disease (UCKD) in Washington, D.C., bringing healthcare professionals, researchers, ...

Updated consumer resource explains eGFR and UACR testing, individualized nutrition, medication oversight and how to ...

Treatment of chronic kidney disease (CKD) focuses on slowing disease progression toward kidney failure, reducing cardiovascular risk, and addressing complications such as anemia and mineral bone ...

Chronic kidney disease often develops without obvious symptoms, but your body may show important warning signs long before ...

Chronic kidney disease of unknown origin (CKDu) is an ongoing global health concern and public health challenge. Often ...

The terms renal failure and kidney failure are often used interchangeably, but they carry slightly different connotations. Both describe the same medical condition, a significant loss of kidney ...

Kidney disease is often diagnosed late in many African Americans, but there are signs to look for to help eliminate late ...

Scientists have identified microRNA able to protect small blood vessels and support kidney function after severe injury. In a world first, Canadian scientists at the CRCHUM, the hospital research ...

Chronic kidney disease (CKD) represents a significant global health burden, highlighting the need for low-cost, easily accessible biomarkers for early risk detection. The neutrophil-to-lymphocyte ...

Within five years of a type 2 diabetes diagnosis, there is a greater risk of developing chronic kidney disease (CKD) first ...